Results 91 to 100 of about 20,046 (138)
Rediscovering cytisine: Why the WHO's decision matters for global public health. [PDF]
iSciencePolosa R, Cohen G.
europepmc +1 more source
Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System. [PDF]
Int J Clin PharmSeijas-Amigo J +6 more
europepmc +1 more source
Comparing adaptive treatment strategies in two-stage randomized trials with grouped survival data. [PDF]
Lifetime Data AnalSparkman M, Halabi S, Li Z.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drug Intelligence & Clinical Pharmacy, 1984
Bupropion is a trimethylated monocyclic phenylaminoketone that is an effective antidepressant in humans. It neither is sedating, anticholinergic, nor cardiotoxic. Its mechanism of action may be related to dopamine, but remains uncertain at this time. Clinical trials comparing bupropion 300–750 mg/d with placebo show it to be superior ...
Dufresne, R., Weber, S., Becker, R. E.
openaire +3 more sources
Bupropion is a trimethylated monocyclic phenylaminoketone that is an effective antidepressant in humans. It neither is sedating, anticholinergic, nor cardiotoxic. Its mechanism of action may be related to dopamine, but remains uncertain at this time. Clinical trials comparing bupropion 300–750 mg/d with placebo show it to be superior ...
Dufresne, R., Weber, S., Becker, R. E.
openaire +3 more sources